Pentwater Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Pentwater Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,240,000	Closed	-$205M	–	359
2021 Q2	$205M	Buy	1,240,000 +310,332	+33%	+$51.8M	1.69%	15
2021 Q1	$143M	Buy	+929,668	New	+$126M	1.36%	18

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Pentwater Capital Management's PRAH Position: Q3 2021 in Review

Pentwater Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 1,240,000 shares — an estimated $205M sold.

Pentwater Capital Management first reported a position in PRAH in Q1 2021 and held it in 2 quarters. The position peaked at $205M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Pentwater Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Pentwater Capital Management sold 1,240,000 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $205M.
Pentwater Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 2 quarters.
Pentwater Capital Management's PRA Health Sciences, Inc. position peaked at $205M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Pentwater Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.